<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml">
   <article xmlns="" xmlns:xlink="http://www.w3.org/1999/xlink">
      <head>
         <style type="text/css"> 		 
            	    table {background : #ffffdd;}
            		 	tr {background : #ddddff; padding : 1px;}
            			
         </style>
         <span class="citation_publisher">BioMed Central</span>
         <h2 class="citation-title">Attacking pathogens through their hosts</h2>
         <span class="doi">10.1186/gb-2006-7-1-201</span>
         <div class="contrib-group">contrib: 
            	  CONT
            	  
            <span class="citation_author">Paul Kellam</span>
            <span class="citation_author_institution_ref"></span>
         </div>
         <span class="email">[]</span>
         <span class="conflict">[]</span>
         <span class="contribs">[]</span>
         <span class="citation_pubdate">[2006-1-30]</span>
         <span class="citation_copyright">[Copyright : ]</span>
         <span class="citation_licence">[Licence ]</span>
         <span class="citation_funding">[]</span>
         <span class="citation_pagecount">[]</span>
         <span class="citation_data">[]</span>
      </head>
      <div id="abstract" tag="abstract">
         <h2>Abstract</h2>
         <p>Through understanding the intricacies of host-pathogen interactions, it is now possible
            to inhibit the growth of microbes, especially viruses, by targeting host-cell proteins
            and functions. 
         </p>
      </div>
      <div id="abstract" tag="abstract">
         <h2>Abstract</h2>
         <p>Through understanding the intricacies of host-pathogen interactions, it is now possible
            to inhibit the growth of microbes, especially viruses, by targeting host-cell proteins
            and functions. This new antimicrobial strategy has proved effective in the laboratory
            and in the clinic, and it has great potential for the future.
         </p>
      </div>
      <div tagxxx="sec">
         <title></title>
         <p>It is now clear that, despite the optimism of the 1967 US Surgeon General in stating
            that 'it's time to close the book on infectious diseases', implying that drugs such
            as antibiotics had made microbial diseases a thing of the past, infectious diseases
            remain a major cause of continuing human suffering. It is estimated that infectious
            diseases currently account for one third of global annual deaths. This led the more
            recent 16th US Surgeon General, David Satcher, to state that 'we are seeing a global
            resurgence of infectious disease'. Finding ways to treat these diseases is a continuing
            battle, and any new avenues for discovering therapeutics should be explored.
         </p>
      </div>
      <div tagxxx="sec">
         <title>Current approaches to antimicrobial drug development</title>
         <p>The paradigm of antimicrobial drugs, be they against viruses, bacteria, fungi or parasites,
            has been to target unique processes or enzymes of the pathogen with a specific drug,
            thus achieving a high antimicrobial effect and low host-cell toxicity because there
            is no cross-inhibition of host-cell proteins. This paradigm has been used to develop
            almost all current antimicrobial therapies, with many notable successes, and it will
            continue to be an important drug-development strategy in the future [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>,
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>]. Even when pressure from a drug results in the selection of drug-resistant variants,
            the antimicrobial drug pipeline has delivered new therapies that allow us to stay
            ahead - in some cases just ahead - of a resurgence of old microbial diseases [
            <span ref-type="bibr" rid="B3">
               <sup>
                  <a href="#B3">3</a>
               </sup>
            </span>].
         </p>
         <p>Despite this success, it is clear that the pipeline of new antimicrobial drugs is
            not full, and it may never be possible to develop drugs targeted to all the diverse
            pathogens that cause disease. This is partly because the disease burden of any one
            pathogen is unlikely to reach sufficient levels for pharmaceutical companies to justify
            the enormous cost of developing a new drug, which (although hotly debated) is estimated
            to be between $0.5 billion and $1.7 billion [
            <span ref-type="bibr" rid="B4">
               <sup>
                  <a href="#B4">4</a>
               </sup>
            </span>-
            <span ref-type="bibr" rid="B6">
               <sup>
                  <a href="#B6">6</a>
               </sup>
            </span>]. Although legislation over the past 20 years in the USA, especially the 'Orphan
            Drug Act', is designed to reduce such barriers, the difficulty of developing new antimicrobial
            drugs remains, and it is compounded by the fact that many infectious diseases requiring
            treatment occur in developing countries, which cannot cope with the costs of new drugs.
            In addition, the fact that multiple companies develop drugs against the same 'important'
            pathogen dilutes an already limited market share; this can be beneficial, however,
            when drug combination therapy is used to reduce the selection for drug resistance
            in, for example, human immunodeficiency virus (HIV) in patients with acquired immune
            deficiency syndrome (AIDS).
         </p>
         <p>Broad-spectrum antibiotics are a way to expand the number of diseases that are treatable
            with the same medicine, but in the field of antiviral drugs such broad-spectrum classes
            of drug are less common. Even despite the massive sequencing of microbial genomes,
            which has identified many new drug targets, the classic antimicrobial paradigm cannot
            quickly deliver what we need. Given that encounters with existing or new microbial
            pathogens are unlikely to decrease [
            <span ref-type="bibr" rid="B7">
               <sup>
                  <a href="#B7">7</a>
               </sup>
            </span>], can we find a new way of combating microbial disease? Evidence suggests that we
            can, and that by using genome-scale approaches to identifying critical host-cell functions
            that facilitate microbial replication, we may be able to unlock new potential in both
            existing and future drugs.
         </p>
      </div>
      <div tagxxx="sec">
         <title>New approaches to antiviral therapy</title>
         <p>It is clear that all pathogenic microorganisms interact in some way with host tissues
            and cells during the disease process. These interactions can now be viewed at the
            level of whole-genome transcriptional responses [
            <span ref-type="bibr" rid="B8">
               <sup>
                  <a href="#B8">8</a>
               </sup>
            </span>,
            <span ref-type="bibr" rid="B9">
               <sup>
                  <a href="#B9">9</a>
               </sup>
            </span>]. In the case of viruses the interaction is obligatory, as viruses require the host-cell
            environment to replicate. It is the viral world that provides clues to how we could
            acquire a new range of antimicrobial drugs at relatively little cost and on a short
            timescale.
         </p>
         <p>The concept of attacking the microbe by altering or augmenting a host-cell function
            or process is not new. The use of interferon α (IFNα) in combination with ribavirin
            in the treatment of hepatitis C virus infection is successful in 50% of infected individuals
            on a long-term basis [
            <span ref-type="bibr" rid="B10">
               <sup>
                  <a href="#B10">10</a>
               </sup>
            </span>,
            <span ref-type="bibr" rid="B11">
               <sup>
                  <a href="#B11">11</a>
               </sup>
            </span>], although the exact mode of action, and the reasons why 50% of people do not respond
            fully, are not understood. Similarly, interleukin-2 (IL-2) has been used to augment
            'highly active antiretroviral therapy' (HAART) in HIV infection (HAART is a multiple
            drug combination therapy with higher antiviral activity than therapy with a single
            drug). Although this does not directly affect the viral load in the peripheral blood,
            it accelerates the normalization of CD4
            <sup>+ </sup>T-cell counts in infected individuals (HIV-infected individuals have reduced numbers
            of T cells bearing the CD4 cell-surface molecule because of the effects of HIV replication)
            [
            <span ref-type="bibr" rid="B12">
               <sup>
                  <a href="#B12">12</a>
               </sup>
            </span>].
         </p>
         <p>Recently, however, a new anti-infective paradigm has emerged, a logical extension
            of INFα and IL-2 therapies but more sophisticated. Because pathogens, especially viruses,
            use host-cell pathways and enzymes for their replicative life cycle, it seems reasonable
            to expect that inhibiting such cellular processes would have an antiviral effect as
            a byproduct. There is now ample evidence, both 
            <i>in vitro </i>and 
            <i>in vivo</i>, that this is an effective strategy. Moreover, because all existing licensed drugs
            that target a human disease process affect the functioning of a cell or organ system
            in some way, we have in effect a ready-made pharmacy of antimicrobial agents with
            defined safety-data profiles and clinical-use histories that only require assessment
            for new or 'off target' second use.
         </p>
         <div tagxxx="sec">
            <h3>Inhibiting host-cell functions produces an antiviral effect</h3>
            <p>The evidence that the approach of inhibiting host-cell functions works now extends
               across many diverse virus types, including poxviruses [
               <span ref-type="bibr" rid="B13">
                  <sup>
                     <a href="#B13">13</a>
                  </sup>
               </span>], herpesviruses [
               <span ref-type="bibr" rid="B14">
                  <sup>
                     <a href="#B14">14</a>
                  </sup>
               </span>-
               <span ref-type="bibr" rid="B16">
                  <sup>
                     <a href="#B16">16</a>
                  </sup>
               </span>], retroviruses [
               <span ref-type="bibr" rid="B17">
                  <sup>
                     <a href="#B17">17</a>
                  </sup>
               </span>], hepadnaviruses [
               <span ref-type="bibr" rid="B18">
                  <sup>
                     <a href="#B18">18</a>
                  </sup>
               </span>,
               <span ref-type="bibr" rid="B19">
                  <sup>
                     <a href="#B19">19</a>
                  </sup>
               </span>] and flaviviruses [
               <span ref-type="bibr" rid="B20">
                  <sup>
                     <a href="#B20">20</a>
                  </sup>
               </span>] (Table 
               <span ref-type="table" rid="T1">
                  <a href="#T1">1</a>
               </span>). But how were these novel antiviral targets discovered? In some cases, the insight
               came from basic knowledge of cellular enzymes and pathways with which the viral proteins
               interact. In other cases, genome-scale approaches such as gene-expression profiling
               using DNA microarrays identified genes, upregulated as part of the infected cell response,
               that were also known targets for drugs.
            </p>
            <p>There are at least three possible functions of these upregulated genes. First, they
               may be induced specifically by a given virus to facilitate efficient virus replication.
               Second, they may be induced as part of the cellular response to the pathogen and cause
               disease pathogenesis. And third, they may be part of the cellular response leading
               to pathogen clearance. Targeting genes in the first and second categories should lead
               to reduced virus replication and attenuated disease pathogenesis, whereas inhibiting
               genes involved in pathogen clearance should be avoided.
            </p>
            <p>The antiviral properties that have been described for Gleevec (Imatinib mesylate),
               which was originally licensed for the treatment of chronic myelogenous leukemia and
               inhibits the Abl tyrosine kinase, exemplify the advantages of target discovery that
               uses both basic knowledge and the genome-scale approach. Knowledge that the protein
               A36R of the vaccinia virus, a poxvirus, is phosphorylated by both Src and Abl receptor
               tyrosine kinases led Reeves 
               <i>et al</i>. [
               <span ref-type="bibr" rid="B13">
                  <sup>
                     <a href="#B13">13</a>
                  </sup>
               </span>] to examine the effects of inhibiting A36R phosphorylation. It became evident that
               Gleevec not only decreased virus titer and plaque size in tissue culture, but also
               prevented the effects of a lethal dose of vaccinia in a mouse nasal challenge assay,
               showing that Gleevec had the potential to limit the spread of vaccinia 
               <i>in vivo</i>.
            </p>
            <p>For the Kaposi's sarcoma herpesvirus (KSHV), infection of endothelial cells 
               <i>in vitro </i>results in a change in cellular morphology from cobblestone-like to a spindle-cell
               appearance reminiscent of Kaposi's sarcoma (KS) cells. This was shown by Moses 
               <i>et al</i>. [
               <span ref-type="bibr" rid="B14">
                  <sup>
                     <a href="#B14">14</a>
                  </sup>
               </span>] to coincide with increased expression of c-Kit, another target of Gleevec. Gleevec
               was tested and shown to prevent this change in cellular morphology 
               <i>in vitro </i>[
               <span ref-type="bibr" rid="B14">
                  <sup>
                     <a href="#B14">14</a>
                  </sup>
               </span>]. More recently, the results of a small clinical study showed that Gleevec also reduced
               tumor size in 50% of people with KS [
               <span ref-type="bibr" rid="B21">
                  <sup>
                     <a href="#B21">21</a>
                  </sup>
               </span>].
            </p>
            <p>An inhibitor of another KSHV-mediated cellular effect, B-cell lymphoma development,
               was also identified through changes in gene-expression patterns. My colleagues and
               I [
               <span ref-type="bibr" rid="B16">
                  <sup>
                     <a href="#B16">16</a>
                  </sup>
               </span>] identified the vitamin D receptor as being highly expressed in a subset of B-cell
               lymphomas, including KSHV primary effusion lymphoma, and showed by using a vitamin
               D receptor analog that the proliferation of these tumors could be greatly reduced
               
               <i>in vitro</i>. Similarly, changes in gene expression following human cytomegalovirus (HCMV) infection
               
               <i>in vitro </i>showed increased expression of cyclooxygenase 2 (COX-2) [
               <span ref-type="bibr" rid="B22">
                  <sup>
                     <a href="#B22">22</a>
                  </sup>
               </span>]. COX-2, a component of the prostaglandin H2 synthase complex, which is part of the
               eicosanoid biosynthesis pathway, catalyzes the production of prostaglandin H2 from
               arachidonic acid. Using COX-2 inhibitors, Zhu 
               <i>et al</i>. [
               <span ref-type="bibr" rid="B15">
                  <sup>
                     <a href="#B15">15</a>
                  </sup>
               </span>] went on to show that HCMV titer could be reduced by two orders of magnitude 
               <i>in vitro</i>. This result fits with the fact that inhibitors of the eicosanoid pathway, such as
               aspirin (a nonsteroidal anti-inflammatory drug that inhibits COX-1 and COX-2), also
               inhibit HCMV replication [
               <span ref-type="bibr" rid="B23">
                  <sup>
                     <a href="#B23">23</a>
                  </sup>
               </span>]. The importance of COX-2 to cytomegalovirus replication is highlighted further by
               the fact that the related rhesus cytomegalovirus (RhCMV), which infects rhesus macaques,
               encodes its own COX-2 ortholog [
               <span ref-type="bibr" rid="B24">
                  <sup>
                     <a href="#B24">24</a>
                  </sup>
               </span>]. Although the long-term use of COX-2 inhibitors results in an increased risk of
               cardiovascular toxicity in some individuals, a fact that has resulted in the withdrawal
               of the drugs for treating arthritis, it is possible that short-term use of the drug
               would be useful and safe in the treatment of acute HCMV disease.
            </p>
            <p>Two other approved drugs have shown promising effects in the treatment of viral disease;
               in fact, they converge on a common cellular pathway but affect different components
               and different viruses (Figure 
               <span ref-type="fig" rid="F1">1</span>). Prenylation, a specific lipid modification of proteins that promotes their association
               with membranes, is known to be required for the maturation of infectious hepatitis
               delta virus (HDV). Co-infection of HDV with hepatitis B virus (HBV) causes rapid progression
               to chronic liver disease. But HDV is a replication-defective virus that requires the
               HBV surface antigen to become infectious, and the acquisition of this antigen depends
               on the HDV large delta antigen, a protein that has a prenylation motif recognized
               by the enzyme farnesyltransferase. Inhibitors of farnesyltransferase have been developed
               to prevent prenylation of Ras and the subsequent association of Ras with membranes,
               thereby reducing its transforming properties. Bordier 
               <i>et al</i>. [
               <span ref-type="bibr" rid="B18">
                  <sup>
                     <a href="#B18">18</a>
                  </sup>
               </span>,
               <span ref-type="bibr" rid="B19">
                  <sup>
                     <a href="#B19">19</a>
                  </sup>
               </span>] have shown that farnesyltransferase inhibitors reduced HDV infectious virion production
               [
               <span ref-type="bibr" rid="B18">
                  <sup>
                     <a href="#B18">18</a>
                  </sup>
               </span>] and also reduced HDV viral load, as assessed by the number of viral RNA copies in
               the serum of an experimental mouse model for HDV liver infection [
               <span ref-type="bibr" rid="B19">
                  <sup>
                     <a href="#B19">19</a>
                  </sup>
               </span>]. This raises the important possibility that prenylation inhibitors, which are known
               to have low side effects, could be a new class of antiviral agents [
               <span ref-type="bibr" rid="B25">
                  <sup>
                     <a href="#B25">25</a>
                  </sup>
               </span>].
            </p>
         </div>
         <div tagxxx="sec">
            <h3>Inhibiting HIV-1 replication</h3>
            <p>Applying to HIV infections the approach of looking for known drugs that also affect
               viruses has resulted in new potential treatment options. The upregulation of genes
               involved in cholesterol biosynthesis pathways has been observed by gene-expression
               studies of HIV-infected cells 
               <i>in vitro</i>. The upregulation increases the cellular levels of cholesterol, an effect mediated
               by the HIV protein Nef [
               <span ref-type="bibr" rid="B26">
                  <sup>
                     <a href="#B26">26</a>
                  </sup>
               </span>,
               <span ref-type="bibr" rid="B27">
                  <sup>
                     <a href="#B27">27</a>
                  </sup>
               </span>]. Cholesterol-lowering drugs such as statins, which inhibit 3-hydroxy-3-methyl-glutaryl-CoA
               (HMG-CoA) reductase, the rate-limiting enzyme in the cholesterol biosynthetic pathway,
               might therefore have an antiviral effect on HIV.
            </p>
            <p>In a ground breaking study, del Real 
               <i>et al</i>. [
               <span ref-type="bibr" rid="B17">
                  <sup>
                     <a href="#B17">17</a>
                  </sup>
               </span>] tested the effect of statins on HIV replication both 
               <i>in vitro </i>and 
               <i>in vivo</i>. Amazingly, statins both inhibited HIV replication in culture, an effect that could
               be reversed by bypassing HMG-CoA reductase by adding the enzyme's product mevalonate
               (see Figure 
               <span ref-type="fig" rid="F1">1</span>), and reduced HIV viral load by greater than threefold in six patients treated for
               one month. Interestingly, del Real 
               <i>et al</i>. [
               <span ref-type="bibr" rid="B17">
                  <sup>
                     <a href="#B17">17</a>
                  </sup>
               </span>] showed that the anti-HIV effect of the statins was mediated by geranylgeranyl pyrophosphate,
               the other prenyl lipid involved in prenylating proteins. Inhibition of geranylgeranyltransferase
               I with a small-molecule inhibitor recapitulated the anti-HIV effect of the statin,
               whereas far-nesyltransferase inhibitors had no effect. Geranylgeranylation is required
               for post-translational modification of Rho GTPases, and the HIV envelope protein activates
               Rho upon binding the cell surface; it is therefore possible that the anti-HIV effects
               of statins occur through disruption of Rho activation, required for efficient virus
               entry into the cell, that is induced by the HIV envelope protein gp120 [
               <span ref-type="bibr" rid="B17">
                  <sup>
                     <a href="#B17">17</a>
                  </sup>
               </span>].
            </p>
            <p>HIV replication can also be inhibited by targeting other cellular functions. Several
               studies have shown that the cellular mechanisms responsible for repairing DNA double-strand
               breaks are required to support retroviral infection and prevent cell death. Lau 
               <i>et al</i>. [
               <span ref-type="bibr" rid="B28">
                  <sup>
                     <a href="#B28">28</a>
                  </sup>
               </span>] demonstrated that the ataxia-telangiectasia (ATM) kinase, one of the cellular regulators
               of responses to DNA damage, is activated by integration of the HIV genome into the
               host-cell genome. Inhibiting ATM kinase activity efficiently blocked HIV replication
               in T cells by inducing cell death in the infected cells, most probably as a result
               of an impaired ability to repair DNA double-stranded breaks arising from retroviral
               genome integration. Inhibiting ATM kinase also worked synergistically with existing
               antiretroviral drugs [
               <span ref-type="bibr" rid="B28">
                  <sup>
                     <a href="#B28">28</a>
                  </sup>
               </span>].
            </p>
            <p>By a similar rationale, Hauber 
               <i>et al</i>. [
               <span ref-type="bibr" rid="B29">
                  <sup>
                     <a href="#B29">29</a>
                  </sup>
               </span>] used knowledge about the HIV Rev protein to identify a novel antiviral agent: Rev
               uses the eukaryotic initiation factor 5A (eIF-5a) as a cofactor for the nuclear export
               of unspliced viral RNAs containing the Rev-responsive element. Activity is conferred
               on eIF-5a by the modification of the amino acid lysine to hypusine. The catalysis
               of the hypusine modification is achieved by two enzymes, deoxyhypusine synthase (DHS)
               and deoxyhypusine hydrolase. A small-molecule inhibitor of DHS, CNI-1493, is known
               to have antiproliferative effects on human cells 
               <i>in vitro </i>and is currently being assessed clinically for the treatment of Crohn's disease. Hauber
               
               <i>et al</i>. [
               <span ref-type="bibr" rid="B29">
                  <sup>
                     <a href="#B29">29</a>
                  </sup>
               </span>] showed that CNI-1493 could inhibit HIV replication 
               <i>in vitro </i>at drug concentrations below those that are being used in the clinical trials, suggesting
               that CNI-1493 is also a potential antiviral.
            </p>
         </div>
         <div tagxxx="sec">
            <h3>Inhibition of basic host-cell functions</h3>
            <p>Targeting aspects of the host mRNA transport and translation initiation mechanisms
               are also ways of inhibiting herpes simplex virus (HSV) and HBV replication. Research
               aimed at protecting cells from endoplasmic reticulum (ER) stress showed that the small
               molecule salubrinal could block dephosphorylation of the eukaryotic initiation factor
               eIF-2α, and that this inhibited HSV replication. All eukaryotic cells respond to ER
               stress, including the stress induced by viral infection, by inducing a set of pathways
               known collectively as the unfolded protein response. The unfolded protein response
               leads in part to the phosphorylation of eIF-2α and subsequent transient translational
               arrest, a cytoprotective response. Virus infection can also induce eIF-2α phosphorylation
               through the double-stranded RNA-activated protein kinase (PKR). To counteract this
               activity HSV encodes a protein (ICP34.5) that interacts with cellular proteins to
               mediate eIF-2α dephosphorylation.
            </p>
            <p>Testing of salubrinal in an HSV-infection assay showed that the small molecule could
               block HSV-mediated eIF-2α dephosphorylation and prevent HSV replication [
               <span ref-type="bibr" rid="B30">
                  <sup>
                     <a href="#B30">30</a>
                  </sup>
               </span>]. Similarly, knowledge that the HBV genome enhancer region binds heterogeneous nuclear
               ribonucleoprotein K (hnRNP K), a pre-mRNA-binding protein that shuttles between the
               nucleus and cytoplasm, led Ng 
               <i>et al</i>. [
               <span ref-type="bibr" rid="B31">
                  <sup>
                     <a href="#B31">31</a>
                  </sup>
               </span>] to remove hnRNP K using RNA interference (RNAi) gene silencing and to demonstrate
               that this reduces HBV DNA replication by up to 50%.
            </p>
            <p>The ability to target host-cell proteins as antivirals is not limited to DNA viruses
               (poxviruses and herpesviruses) or viruses that use DNA intermediates as part of their
               replicative life cycle (hepadnaviruses and retroviruses). Studies of gene-expression
               changes caused by infection with West Nile virus (WNV), a flavivirus the genome of
               which consists of a single-stranded positive-sense RNA molecule, showed that the gene
               encoding the Src-family kinase (SFK) c-Yes was upregulated fivefold [
               <span ref-type="bibr" rid="B20">
                  <sup>
                     <a href="#B20">20</a>
                  </sup>
               </span>]. Specifically inhibiting SFKs with small molecules and removing c-Yes by RNAi significantly
               inhibited WNV replication 
               <i>in vitro </i>[
               <span ref-type="bibr" rid="B20">
                  <sup>
                     <a href="#B20">20</a>
                  </sup>
               </span>].
            </p>
         </div>
         <div tagxxx="sec">
            <h3>Treating persistent virus infections</h3>
            <p>Many viruses, especially herpesviruses and retroviruses, persist for the lifetime
               of the host after the initial infection. These 'latent' infections are the source
               of continued virus production, but they are generally not affected by the range of
               drugs that target the lytic side of the viral life cycle. Recently, the prospect of
               using licensed drugs to deplete latently HIV-infected cells in patients has shown
               promising results.
            </p>
            <p>Histone deacetylase 1 (HDAC1), which mediates chromatin remodeling, has been implicated
               in the repression of HIV gene expression in infected cells, and inhibition of HDAC1
               by the anticonvulsant valporic acid (VPA) results in reactivation of HIV-1 replication
               in latently infected T cells [
               <span ref-type="bibr" rid="B32">
                  <sup>
                     <a href="#B32">32</a>
                  </sup>
               </span>]. This may seem like a bad effect, but it raises the possibility of using VPA to
               induce a 'flushing out' of latently infected cells in combination with antiretroviral
               drugs to prevent infection of new cells. The idea was tested in a small group of patients,
               and the combination of VPA and the antiretroviral enfuvirtide resulted in a significant
               decline in latently infected resting T cells [
               <span ref-type="bibr" rid="B33">
                  <sup>
                     <a href="#B33">33</a>
                  </sup>
               </span>]. It may therefore be possible in the future to reactivate latent virus infections
               in a controlled way and thereby perhaps eliminate the virus from the individual completely.
            </p>
         </div>
      </div>
      <div tagxxx="sec">
         <title>Systematic hunting for new antiviral targets</title>
         <p>Together, the approaches described above provide sufficient evidence that targeting
            host-cell processes is a good approach to finding new antiviral drugs. More of the
            same kind of research will clearly uncover other cell processes that can be similarly
            inhibited. Fewer than half of the studies discussed so far, however, used DNA microarray
            technology to provide the first clue to which drug to use [
            <span ref-type="bibr" rid="B14">
               <sup>
                  <a href="#B14">14</a>
               </sup>
            </span>-
            <span ref-type="bibr" rid="B16">
               <sup>
                  <a href="#B16">16</a>
               </sup>
            </span>,
            <span ref-type="bibr" rid="B20">
               <sup>
                  <a href="#B20">20</a>
               </sup>
            </span>], suggesting that greater use of unbiased approaches will uncover a greater range
            of novel drug targets.
         </p>
         <p>The use of genomics and bioinformatics in drug discovery is now part of the core business
            of many pharmaceutical companies [
            <span ref-type="bibr" rid="B34">
               <sup>
                  <a href="#B34">34</a>
               </sup>
            </span>,
            <span ref-type="bibr" rid="B35">
               <sup>
                  <a href="#B35">35</a>
               </sup>
            </span>]. This has resulted in a rationalization of the sort of data required and how they
            are integrated to facilitate discovery of new drugs. The simplest unbiased approach
            to finding new antivirals would be to assess systematically the gene-expression changes
            induced in appropriate target cells by a range of viruses, and then link the induced
            genes to known drugs that target the protein or pathway encoded by the induced genes.
            This can be undertaken 
            <i>in vitro</i>, as the data generated from appropriate cells seem to be robust and can be translated
            directly into therapies for patients [
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">17</a>
               </sup>
            </span>,
            <span ref-type="bibr" rid="B21">
               <sup>
                  <a href="#B21">21</a>
               </sup>
            </span>,
            <span ref-type="bibr" rid="B33">
               <sup>
                  <a href="#B33">33</a>
               </sup>
            </span>].
         </p>
         <p>As it is unlikely that one laboratory will generate all possible virus-induced host
            gene-expression data, it is clear that data sharing and integration will be required,
            an idea championed by the Katze laboratory through their view of a 'virus compendium'
            to capture such information [
            <span ref-type="bibr" rid="B36">
               <sup>
                  <a href="#B36">36</a>
               </sup>
            </span>]. If such a compendium were integrated with data on existing drugs and their protein
            or pathway targets, we would have an easily accessible means of finding potential
            antivirals. Even in the absence of a unified compendium, meta-analysis of host gene-expression
            programs altered by infection has revealed over 500 genes that can now be explored
            [
            <span ref-type="bibr" rid="B9">
               <sup>
                  <a href="#B9">9</a>
               </sup>
            </span>]. If these are not direct targets themselves, the clever use of 'pathway expansion'
            methods should reveal alternative proteins that could be used to achieve an antiviral
            effect. Pathway expansion allows a given protein (which may or may not be the target
            of an existing drug) to be placed in a functional pathway, thereby identifying additional
            pathway proteins as potential drug targets. When unraveling the anti-HIV effects of
            statins, knowledge that HMG-CoA reductase is part of the pathway producing farnesyl
            and geranyl pyrophosphate (see Figure 
            <span ref-type="fig" rid="F1">1</span>) allowed the identification of farnesyl- and geranyltransferase inhibitors as additional
            drugs in the expanded pathway [
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">17</a>
               </sup>
            </span>].
         </p>
         <p>To find more general targets, this strategy could be integrated with high-throughput
            loss-of-function assays, in which the function being assessed is the ability of the
            cells to support viral replication. This could be undertaken either in model systems
            or in cell types that can actually be infected by the viruses of interest. The idea
            of using model systems stems from the work of two groups [
            <span ref-type="bibr" rid="B37">
               <sup>
                  <a href="#B37">37</a>
               </sup>
            </span>-
            <span ref-type="bibr" rid="B39">
               <sup>
                  <a href="#B39">39</a>
               </sup>
            </span>], who assessed yeast single-gene-deletion libraries for their ability to support
            the replication of RNA virus genomes. Each study identified a range of yeast genes
            that were required for viral-genome replication or recombination. A concern must be
            raised about the low level of concordance between genes identified by the two groups,
            however. In fact, comparing genes required for tomato bushy stunt virus (TBSV) replication
            with those for brome mosaic virus (BMV) replication identified only four genes needed
            for both viruses. This small overlap can be explained in part by different experimental
            systems and the fact that TBSV and BMV represent different supergroups of viruses.
            Nevertheless, the real proof that these surrogate systems are meaningful will require
            testing the effect of inhibiting some of the genes in real viral replication systems.
         </p>
         <p>A more authentic method, and one supported by some of the examples described above,
            would be the large-scale loss-of-function screening of human cells with RNAi libraries
            [
            <span ref-type="bibr" rid="B40">
               <sup>
                  <a href="#B40">40</a>
               </sup>
            </span>]. When combined with expression vectors to produce short interfering RNAs (siRNAs),
            such screens have been successful in identifying new modulators of the proliferation
            arrest that is dependent on the transcription factor p53 [
            <span ref-type="bibr" rid="B41">
               <sup>
                  <a href="#B41">41</a>
               </sup>
            </span>].
         </p>
         <p>A related method of using genetic suppressor elements has been used in the context
            of HIV infection. Genetic suppressor elements work by blocking target-gene function
            through an inhibitory RNA or the production of 
            <i>trans</i>-dominant peptides. When used to screen for genes important for HIV infection, this
            method revealed known proteins, such as the chemokine receptor CXCR4 and cyclin T1,
            together with additional proteins that were subsequently confirmed to affect HIV replication
            [
            <span ref-type="bibr" rid="B42">
               <sup>
                  <a href="#B42">42</a>
               </sup>
            </span>]. Such approaches could identify many important host-cell factors, but care will
            be needed to exclude the possibility that they do not induce an apparent antiviral
            response by simply activating classical cellular sensors of viral infection, such
            as PKR.
         </p>
         <p>Combined with existing mechanistic insights into host-pathogen interactions, the coordinated
            use of unbiased, large-scale genomic methods will reveal a richer picture of the integrated
            host-cell response to infection and could well unlock the largely untapped potential
            of inhibiting virus replication through targeting the host. Whether using existing
            drugs in an infectious disease setting will result in additional side effects is not
            known, but the safety profiles of drugs generated from their current clinical use
            suggest that this will not be a large concern. The use of existing drugs for a new
            antiviral purpose, although in some cases not as effective as traditional antiviral
            drugs in preventing virus replication, will also enable combination therapies and
            may be less likely to cause selection for drug-resistant viruses.
         </p>
         <p>In conclusion, the constraints on developing drugs to treat diseases caused by the
            wide variety of microbes has left us with a gap in healthcare that existing and emerging
            pathogens can all too easily colonize. The potential to target host-cell functions
            that prevent or reduce pathogen replication may be a quick and cost-effective way
            to plug this gap.
         </p>
      </div>
      <back>
         <div tag="ref-list">
            <ul>
               <li tag="ref">
                  <a name="B1"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Schmid</span>
                           <span tagx="given-names">MB</span>
                        </name>
                     </span>
                     <span tagx="article-title">Seeing is believing: the impact of structural genomics on antimicrobial drug discovery.</span>
                     <span tagx="source">Nat Rev Microbiol</span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">2</span>
                     <span tagx="fpage">739</span>
                     <span tagx="lpage">746</span>
                     <span class="pub-id'">[15372084]</span>
                     <span class="pub-id'">[10.1038/nrmicro978]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B2"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">De Clercq</span>
                           <span tagx="given-names">E</span>
                        </name>
                     </span>
                     <span tagx="article-title">Strategies in the design of antiviral drugs.</span>
                     <span tagx="source">Nat Rev Drug Discov</span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">1</span>
                     <span tagx="fpage">13</span>
                     <span tagx="lpage">25</span>
                     <span class="pub-id'">[12119605]</span>
                     <span class="pub-id'">[10.1038/nrd703]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B3"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Weber</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Courvalin</span>
                           <span tagx="given-names">P</span>
                        </name>
                     </span>
                     <span tagx="article-title">An emptying quiver: antimicrobial drugs and resistance.</span>
                     <span tagx="source">Emerg Infect Dis</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">11</span>
                     <span tagx="fpage">791</span>
                     <span tagx="lpage">793</span>
                     <span class="pub-id'">[15971372]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B4"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">DiMasi</span>
                           <span tagx="given-names">JA</span>
                        </name>
                        <name>
                           <span tagx="surname">Hansen</span>
                           <span tagx="given-names">RW</span>
                        </name>
                        <name>
                           <span tagx="surname">Grabowski</span>
                           <span tagx="given-names">HG</span>
                        </name>
                     </span>
                     <span tagx="article-title">The price of innovation: new estimates of drug development.</span>
                     <span tagx="source">J Health Econ</span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">22</span>
                     <span tagx="fpage">151</span>
                     <span tagx="lpage">185</span>
                     <span class="pub-id'">[12606142]</span>
                     <span class="pub-id'">[10.1016/S0167-6296(02)00126-1]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B5"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Frank</span>
                           <span tagx="given-names">RG</span>
                        </name>
                     </span>
                     <span tagx="article-title">New estimates of drug development costs.</span>
                     <span tagx="source">J Health Econ</span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">22</span>
                     <span tagx="fpage">325</span>
                     <span tagx="lpage">330</span>
                     <span class="pub-id'">[12606149]</span>
                     <span class="pub-id'">[10.1016/S0167-6296(03)00002-X]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B6"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Mullin</span>
                           <span tagx="given-names">R</span>
                        </name>
                     </span>
                     <span tagx="article-title">Drug development costs about $1.7 billion.</span>
                     <span tagx="source">Chem Eng News</span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">81</span>
                     <span tagx="fpage">8</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B7"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Weiss</span>
                           <span tagx="given-names">RA</span>
                        </name>
                        <name>
                           <span tagx="surname">McMichael</span>
                           <span tagx="given-names">AJ</span>
                        </name>
                     </span>
                     <span tagx="article-title">Social and environmental risk factors in the emergence of infectious diseases.</span>
                     <span tagx="source">Nat Med</span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">10</span>
                     <span tagx="fpage">S70</span>
                     <span tagx="lpage">S76</span>
                     <span class="pub-id'">[15577934]</span>
                     <span class="pub-id'">[10.1038/nm1150]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B8"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Kellam</span>
                           <span tagx="given-names">P</span>
                        </name>
                     </span>
                     <span tagx="article-title">Host-pathogen studies in the post-genomic era.</span>
                     <span tagx="source">Genome Biol</span>
                     <span tagx="year">2000</span>
                     <span tagx="volume">1</span>
                     <span tagx="fpage">reviews1009</span>
                     <span tagx="lpage">1009.4</span>
                     <span class="pub-id'">[11178231]</span>
                     <span class="pub-id'">[10.1186/gb-2000-1-2-reviews1009]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B9"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Jenner</span>
                           <span tagx="given-names">RG</span>
                        </name>
                        <name>
                           <span tagx="surname">Young</span>
                           <span tagx="given-names">RA</span>
                        </name>
                     </span>
                     <span tagx="article-title">Insights into host responses against pathogens from transcriptional profiling.</span>
                     <span tagx="source">Nat Rev Microbiol</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">3</span>
                     <span tagx="fpage">281</span>
                     <span tagx="lpage">294</span>
                     <span class="pub-id'">[15806094]</span>
                     <span class="pub-id'">[10.1038/nrmicro1126]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B10"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Davis</span>
                           <span tagx="given-names">GL</span>
                        </name>
                        <name>
                           <span tagx="surname">Esteban-Mur</span>
                           <span tagx="given-names">R</span>
                        </name>
                        <name>
                           <span tagx="surname">Rustgi</span>
                           <span tagx="given-names">V</span>
                        </name>
                        <name>
                           <span tagx="surname">Hoefs</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Gordon</span>
                           <span tagx="given-names">SC</span>
                        </name>
                        <name>
                           <span tagx="surname">Trepo</span>
                           <span tagx="given-names">C</span>
                        </name>
                        <name>
                           <span tagx="surname">Shiffman</span>
                           <span tagx="given-names">ML</span>
                        </name>
                        <name>
                           <span tagx="surname">Zeuzem</span>
                           <span tagx="given-names">S</span>
                        </name>
                        <name>
                           <span tagx="surname">Craxi</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Ling</span>
                           <span tagx="given-names">M-H</span>
                        </name>
                        <name>
                           <span tagx="surname">Albrecht</span>
                           <span tagx="given-names">J</span>
                        </name>
                     </span>
                     <span tagx="article-title">Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse
                        of chronic hepatitis C.
                     </span>
                     <span tagx="source">N Engl J Med</span>
                     <span tagx="year">1998</span>
                     <span tagx="volume">339</span>
                     <span tagx="fpage">1493</span>
                     <span tagx="lpage">1499</span>
                     <span class="pub-id'">[9819447]</span>
                     <span class="pub-id'">[10.1056/NEJM199811193392102]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B11"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Schalm</span>
                           <span tagx="given-names">SW</span>
                        </name>
                        <name>
                           <span tagx="surname">Hansen</span>
                           <span tagx="given-names">BE</span>
                        </name>
                        <name>
                           <span tagx="surname">Chemello</span>
                           <span tagx="given-names">L</span>
                        </name>
                        <name>
                           <span tagx="surname">Bellobuono</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Brouwer</span>
                           <span tagx="given-names">JT</span>
                        </name>
                        <name>
                           <span tagx="surname">Weiland</span>
                           <span tagx="given-names">O</span>
                        </name>
                        <name>
                           <span tagx="surname">Cavalletto</span>
                           <span tagx="given-names">L</span>
                        </name>
                        <name>
                           <span tagx="surname">Schvarcz</span>
                           <span tagx="given-names">R</span>
                        </name>
                        <name>
                           <span tagx="surname">Ideo</span>
                           <span tagx="given-names">G</span>
                        </name>
                        <name>
                           <span tagx="surname">Alberti</span>
                           <span tagx="given-names">A</span>
                        </name>
                     </span>
                     <span tagx="article-title">Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic
                        hepatitis C. Meta-analysis of individual patient data from European centers.
                     </span>
                     <span tagx="source">J Hepatol</span>
                     <span tagx="year">1997</span>
                     <span tagx="volume">26</span>
                     <span tagx="fpage">961</span>
                     <span tagx="lpage">966</span>
                     <span class="pub-id'">[9186825]</span>
                     <span class="pub-id'">[10.1016/S0168-8278(97)80103-1]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B12"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Stellbrink</span>
                           <span tagx="given-names">HJ</span>
                        </name>
                        <name>
                           <span tagx="surname">van Lunzen</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Westby</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <name>
                           <span tagx="surname">O'Sullivan</span>
                           <span tagx="given-names">E</span>
                        </name>
                        <name>
                           <span tagx="surname">Schneider</span>
                           <span tagx="given-names">C</span>
                        </name>
                        <name>
                           <span tagx="surname">Adam</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Weitner</span>
                           <span tagx="given-names">L</span>
                        </name>
                        <name>
                           <span tagx="surname">Kuhlmann</span>
                           <span tagx="given-names">B</span>
                        </name>
                        <name>
                           <span tagx="surname">Hoffmann</span>
                           <span tagx="given-names">C</span>
                        </name>
                        <name>
                           <span tagx="surname">Fenske</span>
                           <span tagx="given-names">S</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication
                        and proviral DNA (COSMIC trial).
                     </span>
                     <span tagx="source">AIDS</span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">16</span>
                     <span tagx="fpage">1479</span>
                     <span tagx="lpage">1487</span>
                     <span class="pub-id'">[12131185]</span>
                     <span class="pub-id'">[10.1097/00002030-200207260-00004]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B13"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Reeves</span>
                           <span tagx="given-names">PM</span>
                        </name>
                        <name>
                           <span tagx="surname">Bommarius</span>
                           <span tagx="given-names">B</span>
                        </name>
                        <name>
                           <span tagx="surname">Lebeis</span>
                           <span tagx="given-names">S</span>
                        </name>
                        <name>
                           <span tagx="surname">McNulty</span>
                           <span tagx="given-names">S</span>
                        </name>
                        <name>
                           <span tagx="surname">Christensen</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Swimm</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Chahroudi</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Chavan</span>
                           <span tagx="given-names">R</span>
                        </name>
                        <name>
                           <span tagx="surname">Feinberg</span>
                           <span tagx="given-names">MB</span>
                        </name>
                        <name>
                           <span tagx="surname">Veach</span>
                           <span tagx="given-names">D</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases.</span>
                     <span tagx="source">Nat Med</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">11</span>
                     <span tagx="fpage">731</span>
                     <span tagx="lpage">739</span>
                     <span class="pub-id'">[15980865]</span>
                     <span class="pub-id'">[10.1038/nm1265]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B14"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Moses</span>
                           <span tagx="given-names">AV</span>
                        </name>
                        <name>
                           <span tagx="surname">Jarvis</span>
                           <span tagx="given-names">MA</span>
                        </name>
                        <name>
                           <span tagx="surname">Raggo</span>
                           <span tagx="given-names">C</span>
                        </name>
                        <name>
                           <span tagx="surname">Bell</span>
                           <span tagx="given-names">YC</span>
                        </name>
                        <name>
                           <span tagx="surname">Ruhl</span>
                           <span tagx="given-names">R</span>
                        </name>
                        <name>
                           <span tagx="surname">Luukkonen</span>
                           <span tagx="given-names">BG</span>
                        </name>
                        <name>
                           <span tagx="surname">Griffith</span>
                           <span tagx="given-names">DJ</span>
                        </name>
                        <name>
                           <span tagx="surname">Wait</span>
                           <span tagx="given-names">CL</span>
                        </name>
                        <name>
                           <span tagx="surname">Druker</span>
                           <span tagx="given-names">BJ</span>
                        </name>
                        <name>
                           <span tagx="surname">Heinrich</span>
                           <span tagx="given-names">MC</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene,
                        as identified by gene expression profiling, is essential for the transformation of
                        endothelial cells.
                     </span>
                     <span tagx="source">J Virol</span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">76</span>
                     <span tagx="fpage">8383</span>
                     <span tagx="lpage">8399</span>
                     <span class="pub-id'">[12134042]</span>
                     <span class="pub-id'">[10.1128/JVI.76.16.8383-8399.2002]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B15"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Zhu</span>
                           <span tagx="given-names">H</span>
                        </name>
                        <name>
                           <span tagx="surname">Cong</span>
                           <span tagx="given-names">JP</span>
                        </name>
                        <name>
                           <span tagx="surname">Yu</span>
                           <span tagx="given-names">D</span>
                        </name>
                        <name>
                           <span tagx="surname">Bresnahan</span>
                           <span tagx="given-names">WA</span>
                        </name>
                        <name>
                           <span tagx="surname">Shenk</span>
                           <span tagx="given-names">TE</span>
                        </name>
                     </span>
                     <span tagx="article-title">Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication.</span>
                     <span tagx="source">Proc Natl Acad Sci USA</span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">99</span>
                     <span tagx="fpage">3932</span>
                     <span tagx="lpage">3937</span>
                     <span class="pub-id'">[11867761]</span>
                     <span class="pub-id'">[10.1073/pnas.052713799]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B16"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Jenner</span>
                           <span tagx="given-names">RG</span>
                        </name>
                        <name>
                           <span tagx="surname">Maillard</span>
                           <span tagx="given-names">K</span>
                        </name>
                        <name>
                           <span tagx="surname">Cattini</span>
                           <span tagx="given-names">N</span>
                        </name>
                        <name>
                           <span tagx="surname">Weiss</span>
                           <span tagx="given-names">RA</span>
                        </name>
                        <name>
                           <span tagx="surname">Boshoff</span>
                           <span tagx="given-names">C</span>
                        </name>
                        <name>
                           <span tagx="surname">Wooster</span>
                           <span tagx="given-names">R</span>
                        </name>
                        <name>
                           <span tagx="surname">Kellam</span>
                           <span tagx="given-names">P</span>
                        </name>
                     </span>
                     <span tagx="article-title">Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma
                        cell gene expression profile.
                     </span>
                     <span tagx="source">Proc Natl Acad Sci USA</span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">100</span>
                     <span tagx="fpage">10399</span>
                     <span tagx="lpage">10404</span>
                     <span class="pub-id'">[12925741]</span>
                     <span class="pub-id'">[10.1073/pnas.1630810100]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B17"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">del Real</span>
                           <span tagx="given-names">G</span>
                        </name>
                        <name>
                           <span tagx="surname">Jimenez-Baranda</span>
                           <span tagx="given-names">S</span>
                        </name>
                        <name>
                           <span tagx="surname">Mira</span>
                           <span tagx="given-names">E</span>
                        </name>
                        <name>
                           <span tagx="surname">Lacalle</span>
                           <span tagx="given-names">RA</span>
                        </name>
                        <name>
                           <span tagx="surname">Lucas</span>
                           <span tagx="given-names">P</span>
                        </name>
                        <name>
                           <span tagx="surname">Gomez-Mouton</span>
                           <span tagx="given-names">C</span>
                        </name>
                        <name>
                           <span tagx="surname">Alegret</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <name>
                           <span tagx="surname">Pena</span>
                           <span tagx="given-names">JM</span>
                        </name>
                        <name>
                           <span tagx="surname">Rodriguez-Zapata</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <name>
                           <span tagx="surname">Alvarez-Mon</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Statins inhibit HIV-1 infection by down-regulating rho activity.</span>
                     <span tagx="source">J Exp Med</span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">200</span>
                     <span tagx="fpage">541</span>
                     <span tagx="lpage">547</span>
                     <span class="pub-id'">[15314078]</span>
                     <span class="pub-id'">[10.1084/jem.20040061]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B18"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Bordier</span>
                           <span tagx="given-names">BB</span>
                        </name>
                        <name>
                           <span tagx="surname">Marion</span>
                           <span tagx="given-names">PL</span>
                        </name>
                        <name>
                           <span tagx="surname">Ohashi</span>
                           <span tagx="given-names">K</span>
                        </name>
                        <name>
                           <span tagx="surname">Kay</span>
                           <span tagx="given-names">MA</span>
                        </name>
                        <name>
                           <span tagx="surname">Greenberg</span>
                           <span tagx="given-names">HB</span>
                        </name>
                        <name>
                           <span tagx="surname">Casey</span>
                           <span tagx="given-names">JL</span>
                        </name>
                        <name>
                           <span tagx="surname">Glenn</span>
                           <span tagx="given-names">JS</span>
                        </name>
                     </span>
                     <span tagx="article-title">A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.</span>
                     <span tagx="source">J Virol</span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">76</span>
                     <span tagx="fpage">10465</span>
                     <span tagx="lpage">10472</span>
                     <span class="pub-id'">[12239323]</span>
                     <span class="pub-id'">[10.1128/JVI.76.20.10465-10472.2002]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B19"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Bordier</span>
                           <span tagx="given-names">BB</span>
                        </name>
                        <name>
                           <span tagx="surname">Ohkanda</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Liu</span>
                           <span tagx="given-names">P</span>
                        </name>
                        <name>
                           <span tagx="surname">Lee</span>
                           <span tagx="given-names">SY</span>
                        </name>
                        <name>
                           <span tagx="surname">Salazar</span>
                           <span tagx="given-names">FH</span>
                        </name>
                        <name>
                           <span tagx="surname">Marion</span>
                           <span tagx="given-names">PL</span>
                        </name>
                        <name>
                           <span tagx="surname">Ohashi</span>
                           <span tagx="given-names">K</span>
                        </name>
                        <name>
                           <span tagx="surname">Meuse</span>
                           <span tagx="given-names">L</span>
                        </name>
                        <name>
                           <span tagx="surname">Kay</span>
                           <span tagx="given-names">MA</span>
                        </name>
                        <name>
                           <span tagx="surname">Casey</span>
                           <span tagx="given-names">JL</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">
                        <i>In vivo </i>antiviral efficacy of prenylation inhibitors against hepatitis delta virus.
                     </span>
                     <span tagx="source">J Clin Invest</span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">112</span>
                     <span tagx="fpage">407</span>
                     <span tagx="lpage">414</span>
                     <span class="pub-id'">[12897208]</span>
                     <span class="pub-id'">[10.1172/JCI200317704]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B20"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Hirsch</span>
                           <span tagx="given-names">AJ</span>
                        </name>
                        <name>
                           <span tagx="surname">Medigeshi</span>
                           <span tagx="given-names">GR</span>
                        </name>
                        <name>
                           <span tagx="surname">Meyers</span>
                           <span tagx="given-names">HL</span>
                        </name>
                        <name>
                           <span tagx="surname">DeFilippis</span>
                           <span tagx="given-names">V</span>
                        </name>
                        <name>
                           <span tagx="surname">Fruh</span>
                           <span tagx="given-names">K</span>
                        </name>
                        <name>
                           <span tagx="surname">Briese</span>
                           <span tagx="given-names">T</span>
                        </name>
                        <name>
                           <span tagx="surname">Lipkin</span>
                           <span tagx="given-names">WI</span>
                        </name>
                        <name>
                           <span tagx="surname">Nelson</span>
                           <span tagx="given-names">JA</span>
                        </name>
                     </span>
                     <span tagx="article-title">The Src family kinase c-Yes is required for maturation of West Nile virus particles.</span>
                     <span tagx="source">J Virol</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">79</span>
                     <span tagx="fpage">11943</span>
                     <span tagx="lpage">11951</span>
                     <span class="pub-id'">[16140770]</span>
                     <span class="pub-id'">[10.1128/JVI.79.18.11943-11951.2005]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B21"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Koon</span>
                           <span tagx="given-names">HB</span>
                        </name>
                        <name>
                           <span tagx="surname">Bubley</span>
                           <span tagx="given-names">GJ</span>
                        </name>
                        <name>
                           <span tagx="surname">Pantanowitz</span>
                           <span tagx="given-names">L</span>
                        </name>
                        <name>
                           <span tagx="surname">Masiello</span>
                           <span tagx="given-names">D</span>
                        </name>
                        <name>
                           <span tagx="surname">Smith</span>
                           <span tagx="given-names">B</span>
                        </name>
                        <name>
                           <span tagx="surname">Crosby</span>
                           <span tagx="given-names">K</span>
                        </name>
                        <name>
                           <span tagx="surname">Proper</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Weeden</span>
                           <span tagx="given-names">W</span>
                        </name>
                        <name>
                           <span tagx="surname">Miller</span>
                           <span tagx="given-names">TE</span>
                        </name>
                        <name>
                           <span tagx="surname">Chatis</span>
                           <span tagx="given-names">P</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Imatinib-induced regression of AIDS-related Kaposi's sarcoma.</span>
                     <span tagx="source">J Clin Oncol</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">23</span>
                     <span tagx="fpage">982</span>
                     <span tagx="lpage">989</span>
                     <span class="pub-id'">[15572730]</span>
                     <span class="pub-id'">[10.1200/JCO.2005.06.079]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B22"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Zhu</span>
                           <span tagx="given-names">H</span>
                        </name>
                        <name>
                           <span tagx="surname">Cong</span>
                           <span tagx="given-names">JP</span>
                        </name>
                        <name>
                           <span tagx="surname">Mamtora</span>
                           <span tagx="given-names">G</span>
                        </name>
                        <name>
                           <span tagx="surname">Gingeras</span>
                           <span tagx="given-names">T</span>
                        </name>
                        <name>
                           <span tagx="surname">Shenk</span>
                           <span tagx="given-names">T</span>
                        </name>
                     </span>
                     <span tagx="article-title">Cellular gene expression altered by human cytomegalovirus: global monitoring with
                        oligonucleotide arrays.
                     </span>
                     <span tagx="source">Proc Natl Acad Sci USA</span>
                     <span tagx="year">1998</span>
                     <span tagx="volume">95</span>
                     <span tagx="fpage">14470</span>
                     <span tagx="lpage">14475</span>
                     <span class="pub-id'">[9826724]</span>
                     <span class="pub-id'">[10.1073/pnas.95.24.14470]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B23"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Speir</span>
                           <span tagx="given-names">E</span>
                        </name>
                        <name>
                           <span tagx="surname">Yu</span>
                           <span tagx="given-names">ZX</span>
                        </name>
                        <name>
                           <span tagx="surname">Ferrans</span>
                           <span tagx="given-names">VJ</span>
                        </name>
                        <name>
                           <span tagx="surname">Huang</span>
                           <span tagx="given-names">ES</span>
                        </name>
                        <name>
                           <span tagx="surname">Epstein</span>
                           <span tagx="given-names">SE</span>
                        </name>
                     </span>
                     <span tagx="article-title">Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2
                        in coronary artery smooth muscle cells.
                     </span>
                     <span tagx="source">Circ Res</span>
                     <span tagx="year">1998</span>
                     <span tagx="volume">83</span>
                     <span tagx="fpage">210</span>
                     <span tagx="lpage">216</span>
                     <span class="pub-id'">[9686761]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B24"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Rue</span>
                           <span tagx="given-names">CA</span>
                        </name>
                        <name>
                           <span tagx="surname">Jarvis</span>
                           <span tagx="given-names">MA</span>
                        </name>
                        <name>
                           <span tagx="surname">Knoche</span>
                           <span tagx="given-names">AJ</span>
                        </name>
                        <name>
                           <span tagx="surname">Meyers</span>
                           <span tagx="given-names">HL</span>
                        </name>
                        <name>
                           <span tagx="surname">DeFilippis</span>
                           <span tagx="given-names">VR</span>
                        </name>
                        <name>
                           <span tagx="surname">Hansen</span>
                           <span tagx="given-names">SG</span>
                        </name>
                        <name>
                           <span tagx="surname">Wagner</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <name>
                           <span tagx="surname">Fruh</span>
                           <span tagx="given-names">K</span>
                        </name>
                        <name>
                           <span tagx="surname">Anders</span>
                           <span tagx="given-names">DG</span>
                        </name>
                        <name>
                           <span tagx="surname">Wong</span>
                           <span tagx="given-names">SW</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for
                        endothelial cell tropism.
                     </span>
                     <span tagx="source">J Virol</span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">78</span>
                     <span tagx="fpage">12529</span>
                     <span tagx="lpage">12536</span>
                     <span class="pub-id'">[15507640]</span>
                     <span class="pub-id'">[10.1128/JVI.78.22.12529-12536.2004]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B25"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Einav</span>
                           <span tagx="given-names">S</span>
                        </name>
                        <name>
                           <span tagx="surname">Glenn</span>
                           <span tagx="given-names">JS</span>
                        </name>
                     </span>
                     <span tagx="article-title">Prenylation inhibitors: a novel class of antiviral agents.</span>
                     <span tagx="source">J Antimicrob Chemother</span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">52</span>
                     <span tagx="fpage">883</span>
                     <span tagx="lpage">886</span>
                     <span class="pub-id'">[14613953]</span>
                     <span class="pub-id'">[10.1093/jac/dkg490]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B26"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">van 't Wout</span>
                           <span tagx="given-names">AB</span>
                        </name>
                        <name>
                           <span tagx="surname">Swain</span>
                           <span tagx="given-names">JV</span>
                        </name>
                        <name>
                           <span tagx="surname">Schindler</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <name>
                           <span tagx="surname">Rao</span>
                           <span tagx="given-names">U</span>
                        </name>
                        <name>
                           <span tagx="surname">Pathmajeyan</span>
                           <span tagx="given-names">MS</span>
                        </name>
                        <name>
                           <span tagx="surname">Mullins</span>
                           <span tagx="given-names">JI</span>
                        </name>
                        <name>
                           <span tagx="surname">Kirchhoff</span>
                           <span tagx="given-names">F</span>
                        </name>
                     </span>
                     <span tagx="article-title">Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency
                        virus type 1-infected T cells.
                     </span>
                     <span tagx="source">J Virol</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">79</span>
                     <span tagx="fpage">10053</span>
                     <span tagx="lpage">10058</span>
                     <span class="pub-id'">[16014965]</span>
                     <span class="pub-id'">[10.1128/JVI.79.15.10053-10058.2005]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B27"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">van 't Wout</span>
                           <span tagx="given-names">AB</span>
                        </name>
                        <name>
                           <span tagx="surname">Lehrman</span>
                           <span tagx="given-names">GK</span>
                        </name>
                        <name>
                           <span tagx="surname">Mikheeva</span>
                           <span tagx="given-names">SA</span>
                        </name>
                        <name>
                           <span tagx="surname">O'Keeffe</span>
                           <span tagx="given-names">GC</span>
                        </name>
                        <name>
                           <span tagx="surname">Katze</span>
                           <span tagx="given-names">MG</span>
                        </name>
                        <name>
                           <span tagx="surname">Bumgarner</span>
                           <span tagx="given-names">RE</span>
                        </name>
                        <name>
                           <span tagx="surname">Geiss</span>
                           <span tagx="given-names">GK</span>
                        </name>
                        <name>
                           <span tagx="surname">Mullins</span>
                           <span tagx="given-names">JI</span>
                        </name>
                     </span>
                     <span tagx="article-title">Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell
                        lines.
                     </span>
                     <span tagx="source">J Virol</span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">77</span>
                     <span tagx="fpage">1392</span>
                     <span tagx="lpage">1402</span>
                     <span class="pub-id'">[12502855]</span>
                     <span class="pub-id'">[10.1128/JVI.77.2.1392-1402.2003]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B28"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Lau</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Swinbank</span>
                           <span tagx="given-names">KM</span>
                        </name>
                        <name>
                           <span tagx="surname">Ahmed</span>
                           <span tagx="given-names">PS</span>
                        </name>
                        <name>
                           <span tagx="surname">Taylor</span>
                           <span tagx="given-names">DL</span>
                        </name>
                        <name>
                           <span tagx="surname">Jackson</span>
                           <span tagx="given-names">SP</span>
                        </name>
                        <name>
                           <span tagx="surname">Smith</span>
                           <span tagx="given-names">GC</span>
                        </name>
                        <name>
                           <span tagx="surname">O'Connor</span>
                           <span tagx="given-names">MJ</span>
                        </name>
                     </span>
                     <span tagx="article-title">Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase.</span>
                     <span tagx="source">Nat Cell Biol</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">7</span>
                     <span tagx="fpage">493</span>
                     <span tagx="lpage">500</span>
                     <span class="pub-id'">[15834407]</span>
                     <span class="pub-id'">[10.1038/ncb1250]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B29"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Hauber</span>
                           <span tagx="given-names">I</span>
                        </name>
                        <name>
                           <span tagx="surname">Bevec</span>
                           <span tagx="given-names">D</span>
                        </name>
                        <name>
                           <span tagx="surname">Heukeshoven</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Kratzer</span>
                           <span tagx="given-names">F</span>
                        </name>
                        <name>
                           <span tagx="surname">Horn</span>
                           <span tagx="given-names">F</span>
                        </name>
                        <name>
                           <span tagx="surname">Choidas</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Harrer</span>
                           <span tagx="given-names">T</span>
                        </name>
                        <name>
                           <span tagx="surname">Hauber</span>
                           <span tagx="given-names">J</span>
                        </name>
                     </span>
                     <span tagx="article-title">Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral
                        therapy.
                     </span>
                     <span tagx="source">J Clin Invest</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">115</span>
                     <span tagx="fpage">76</span>
                     <span tagx="lpage">85</span>
                     <span class="pub-id'">[15630446]</span>
                     <span class="pub-id'">[10.1172/JCI200521949]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B30"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Boyce</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <name>
                           <span tagx="surname">Bryant</span>
                           <span tagx="given-names">KF</span>
                        </name>
                        <name>
                           <span tagx="surname">Jousse</span>
                           <span tagx="given-names">C</span>
                        </name>
                        <name>
                           <span tagx="surname">Long</span>
                           <span tagx="given-names">K</span>
                        </name>
                        <name>
                           <span tagx="surname">Harding</span>
                           <span tagx="given-names">HP</span>
                        </name>
                        <name>
                           <span tagx="surname">Scheuner</span>
                           <span tagx="given-names">D</span>
                        </name>
                        <name>
                           <span tagx="surname">Kaufman</span>
                           <span tagx="given-names">RJ</span>
                        </name>
                        <name>
                           <span tagx="surname">Ma</span>
                           <span tagx="given-names">D</span>
                        </name>
                        <name>
                           <span tagx="surname">Coen</span>
                           <span tagx="given-names">DM</span>
                        </name>
                        <name>
                           <span tagx="surname">Ron</span>
                           <span tagx="given-names">D</span>
                        </name>
                        <name>
                           <span tagx="surname">Yuan</span>
                           <span tagx="given-names">J</span>
                        </name>
                     </span>
                     <span tagx="article-title">A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress.</span>
                     <span tagx="source">Science</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">307</span>
                     <span tagx="fpage">935</span>
                     <span tagx="lpage">939</span>
                     <span class="pub-id'">[15705855]</span>
                     <span class="pub-id'">[10.1126/science.1101902]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B31"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ng</span>
                           <span tagx="given-names">LF</span>
                        </name>
                        <name>
                           <span tagx="surname">Chan</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <name>
                           <span tagx="surname">Chan</span>
                           <span tagx="given-names">SH</span>
                        </name>
                        <name>
                           <span tagx="surname">Cheng</span>
                           <span tagx="given-names">PC</span>
                        </name>
                        <name>
                           <span tagx="surname">Leung</span>
                           <span tagx="given-names">EH</span>
                        </name>
                        <name>
                           <span tagx="surname">Chen</span>
                           <span tagx="given-names">WN</span>
                        </name>
                        <name>
                           <span tagx="surname">Ren</span>
                           <span tagx="given-names">EC</span>
                        </name>
                     </span>
                     <span tagx="article-title">Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress
                        hepatitis B virus replication.
                     </span>
                     <span tagx="source">PLoS Med</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">2</span>
                     <span tagx="fpage">e163</span>
                     <span class="pub-id'">[16033304]</span>
                     <span class="pub-id'">[10.1371/journal.pmed.0020163]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B32"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ylisastigui</span>
                           <span tagx="given-names">L</span>
                        </name>
                        <name>
                           <span tagx="surname">Archin</span>
                           <span tagx="given-names">NM</span>
                        </name>
                        <name>
                           <span tagx="surname">Lehrman</span>
                           <span tagx="given-names">G</span>
                        </name>
                        <name>
                           <span tagx="surname">Bosch</span>
                           <span tagx="given-names">RJ</span>
                        </name>
                        <name>
                           <span tagx="surname">Margolis</span>
                           <span tagx="given-names">DM</span>
                        </name>
                     </span>
                     <span tagx="article-title">Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent
                        viral expression.
                     </span>
                     <span tagx="source">AIDS</span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">18</span>
                     <span tagx="fpage">1101</span>
                     <span tagx="lpage">1108</span>
                     <span class="pub-id'">[15166525]</span>
                     <span class="pub-id'">[10.1097/00002030-200405210-00003]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B33"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Lehrman</span>
                           <span tagx="given-names">G</span>
                        </name>
                        <name>
                           <span tagx="surname">Hogue</span>
                           <span tagx="given-names">IB</span>
                        </name>
                        <name>
                           <span tagx="surname">Palmer</span>
                           <span tagx="given-names">S</span>
                        </name>
                        <name>
                           <span tagx="surname">Jennings</span>
                           <span tagx="given-names">C</span>
                        </name>
                        <name>
                           <span tagx="surname">Spina</span>
                           <span tagx="given-names">CA</span>
                        </name>
                        <name>
                           <span tagx="surname">Wiegand</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Landay</span>
                           <span tagx="given-names">AL</span>
                        </name>
                        <name>
                           <span tagx="surname">Coombs</span>
                           <span tagx="given-names">RW</span>
                        </name>
                        <name>
                           <span tagx="surname">Richman</span>
                           <span tagx="given-names">DD</span>
                        </name>
                        <name>
                           <span tagx="surname">Mellors</span>
                           <span tagx="given-names">JW</span>
                        </name>
                     </span>
                     <span tagx="article-title">Depletion of latent HIV-1 infection 
                        <i>in vivo</i>: a proof-of-concept study.
                     </span>
                     <span tagx="source">Lancet</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">366</span>
                     <span tagx="fpage">549</span>
                     <span tagx="lpage">555</span>
                     <span class="pub-id'">[16099290]</span>
                     <span class="pub-id'">[10.1016/S0140-6736(05)67098-5]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B34"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Searls</span>
                           <span tagx="given-names">DB</span>
                        </name>
                     </span>
                     <span tagx="article-title">Data integration: challenges for drug discovery.</span>
                     <span tagx="source">Nat Rev Drug Discov</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">4</span>
                     <span tagx="fpage">45</span>
                     <span tagx="lpage">58</span>
                     <span class="pub-id'">[15688072]</span>
                     <span class="pub-id'">[10.1038/nrd1608]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B35"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Kramer</span>
                           <span tagx="given-names">R</span>
                        </name>
                        <name>
                           <span tagx="surname">Cohen</span>
                           <span tagx="given-names">D</span>
                        </name>
                     </span>
                     <span tagx="article-title">Functional genomics to new drug targets.</span>
                     <span tagx="source">Nat Rev Drug Discov</span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">3</span>
                     <span tagx="fpage">965</span>
                     <span tagx="lpage">972</span>
                     <span class="pub-id'">[15520818]</span>
                     <span class="pub-id'">[10.1038/nrd1552]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B36"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Katze</span>
                           <span tagx="given-names">MG</span>
                        </name>
                        <name>
                           <span tagx="surname">He</span>
                           <span tagx="given-names">Y</span>
                        </name>
                        <name>
                           <span tagx="surname">Gale</span>
                           <span tagx="given-names">M</span>
                           <div tagxxx="suffix">Jr</div>
                        </name>
                     </span>
                     <span tagx="article-title">Viruses and interferon: a fight for supremacy.</span>
                     <span tagx="source">Nat Rev Immunol</span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">2</span>
                     <span tagx="fpage">675</span>
                     <span tagx="lpage">687</span>
                     <span class="pub-id'">[12209136]</span>
                     <span class="pub-id'">[10.1038/nri888]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B37"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Kushner</span>
                           <span tagx="given-names">DB</span>
                        </name>
                        <name>
                           <span tagx="surname">Lindenbach</span>
                           <span tagx="given-names">BD</span>
                        </name>
                        <name>
                           <span tagx="surname">Grdzelishvili</span>
                           <span tagx="given-names">VZ</span>
                        </name>
                        <name>
                           <span tagx="surname">Noueiry</span>
                           <span tagx="given-names">AO</span>
                        </name>
                        <name>
                           <span tagx="surname">Paul</span>
                           <span tagx="given-names">SM</span>
                        </name>
                        <name>
                           <span tagx="surname">Ahlquist</span>
                           <span tagx="given-names">P</span>
                        </name>
                     </span>
                     <span tagx="article-title">Systematic, genome-wide identification of host genes affecting replication of a positive-strand
                        RNA virus.
                     </span>
                     <span tagx="source">Proc Natl Acad Sci USA</span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">100</span>
                     <span tagx="fpage">15764</span>
                     <span tagx="lpage">15769</span>
                     <span class="pub-id'">[14671320]</span>
                     <span class="pub-id'">[10.1073/pnas.2536857100]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B38"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Panavas</span>
                           <span tagx="given-names">T</span>
                        </name>
                        <name>
                           <span tagx="surname">Serviene</span>
                           <span tagx="given-names">E</span>
                        </name>
                        <name>
                           <span tagx="surname">Brasher</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Nagy</span>
                           <span tagx="given-names">PD</span>
                        </name>
                     </span>
                     <span tagx="article-title">Yeast genome-wide screen reveals dissimilar sets of host genes affecting replication
                        of RNA viruses.
                     </span>
                     <span tagx="source">Proc Natl Acad Sci USA</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">102</span>
                     <span tagx="fpage">7326</span>
                     <span tagx="lpage">7331</span>
                     <span class="pub-id'">[15883361]</span>
                     <span class="pub-id'">[10.1073/pnas.0502604102]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B39"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Serviene</span>
                           <span tagx="given-names">E</span>
                        </name>
                        <name>
                           <span tagx="surname">Shapka</span>
                           <span tagx="given-names">N</span>
                        </name>
                        <name>
                           <span tagx="surname">Cheng</span>
                           <span tagx="given-names">CP</span>
                        </name>
                        <name>
                           <span tagx="surname">Panavas</span>
                           <span tagx="given-names">T</span>
                        </name>
                        <name>
                           <span tagx="surname">Phuangrat</span>
                           <span tagx="given-names">B</span>
                        </name>
                        <name>
                           <span tagx="surname">Baker</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Nagy</span>
                           <span tagx="given-names">PD</span>
                        </name>
                     </span>
                     <span tagx="article-title">Genome-wide screen identifies host genes affecting viral RNA recombination.</span>
                     <span tagx="source">Proc Natl Acad Sci USA</span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">102</span>
                     <span tagx="fpage">10545</span>
                     <span tagx="lpage">10550</span>
                     <span class="pub-id'">[16027361]</span>
                     <span class="pub-id'">[10.1073/pnas.0504844102]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B40"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Silva</span>
                           <span tagx="given-names">JM</span>
                        </name>
                        <name>
                           <span tagx="surname">Mizuno</span>
                           <span tagx="given-names">H</span>
                        </name>
                        <name>
                           <span tagx="surname">Brady</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Lucito</span>
                           <span tagx="given-names">R</span>
                        </name>
                        <name>
                           <span tagx="surname">Hannon</span>
                           <span tagx="given-names">GJ</span>
                        </name>
                     </span>
                     <span tagx="article-title">RNA interference microarrays: high-throughput loss-of-function genetics in mammalian
                        cells.
                     </span>
                     <span tagx="source">Proc Natl Acad Sci USA</span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">101</span>
                     <span tagx="fpage">6548</span>
                     <span tagx="lpage">6552</span>
                     <span class="pub-id'">[15084744]</span>
                     <span class="pub-id'">[10.1073/pnas.0400165101]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B41"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Berns</span>
                           <span tagx="given-names">K</span>
                        </name>
                        <name>
                           <span tagx="surname">Hijmans</span>
                           <span tagx="given-names">EM</span>
                        </name>
                        <name>
                           <span tagx="surname">Mullenders</span>
                           <span tagx="given-names">J</span>
                        </name>
                        <name>
                           <span tagx="surname">Brummelkamp</span>
                           <span tagx="given-names">TR</span>
                        </name>
                        <name>
                           <span tagx="surname">Velds</span>
                           <span tagx="given-names">A</span>
                        </name>
                        <name>
                           <span tagx="surname">Heimerikx</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <name>
                           <span tagx="surname">Kerkhoven</span>
                           <span tagx="given-names">RM</span>
                        </name>
                        <name>
                           <span tagx="surname">Madiredjo</span>
                           <span tagx="given-names">M</span>
                        </name>
                        <name>
                           <span tagx="surname">Nijkamp</span>
                           <span tagx="given-names">W</span>
                        </name>
                        <name>
                           <span tagx="surname">Weigelt</span>
                           <span tagx="given-names">B</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">A large-scale RNAi screen in human cells identifies new components of the p53 pathway.</span>
                     <span tagx="source">Nature</span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">428</span>
                     <span tagx="fpage">431</span>
                     <span tagx="lpage">437</span>
                     <span class="pub-id'">[15042092]</span>
                     <span class="pub-id'">[10.1038/nature02371]</span>
                  </div>
               </li>
               <li tag="ref">
                  <a name="B42"></a>
                  <div tagxxx="citation">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Dunn</span>
                           <span tagx="given-names">SJ</span>
                        </name>
                        <name>
                           <span tagx="surname">Khan</span>
                           <span tagx="given-names">IH</span>
                        </name>
                        <name>
                           <span tagx="surname">Chan</span>
                           <span tagx="given-names">UA</span>
                        </name>
                        <name>
                           <span tagx="surname">Scearce</span>
                           <span tagx="given-names">RL</span>
                        </name>
                        <name>
                           <span tagx="surname">Melara</span>
                           <span tagx="given-names">CL</span>
                        </name>
                        <name>
                           <span tagx="surname">Paul</span>
                           <span tagx="given-names">AM</span>
                        </name>
                        <name>
                           <span tagx="surname">Sharma</span>
                           <span tagx="given-names">V</span>
                        </name>
                        <name>
                           <span tagx="surname">Bih</span>
                           <span tagx="given-names">F-Y</span>
                        </name>
                        <name>
                           <span tagx="surname">Holzmayer</span>
                           <span tagx="given-names">TA</span>
                        </name>
                        <name>
                           <span tagx="surname">Luciw</span>
                           <span tagx="given-names">PA</span>
                        </name>
                        <name>
                           <span tagx="surname">Abo</span>
                           <span tagx="given-names">A</span>
                        </name>
                     </span>
                     <span tagx="article-title">Identification of cell surface targets for HIV-1 therapeutics using genetic screens.</span>
                     <span tagx="source">Virology</span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">321</span>
                     <span tagx="fpage">260</span>
                     <span tagx="lpage">273</span>
                     <span class="pub-id'">[15051386]</span>
                     <span class="pub-id'">[10.1016/j.virol.2004.01.010]</span>
                  </div>
               </li>
            </ul>
         </div>
         <div tagxxx="sec">
            <title>Figures and Tables</title>
            <fig>
               <label>Figure 1</label>
               <caption>
                  <p>Well characterized drugs that inhibit prenylation can also be used to inhibit viruses.
                     The biosynthetic pathway from acetyl CoA to squalene and then on through multiple
                     other steps (not shown) to ubiquinone, cholesterol and dolichol is shown. Statins
                     inhibit HMG-CoA reductase and thereby prevent the synthesis of mevalonate and subsequent
                     downstream lipids; statins also inhibit the replication of HIV [17]. Farnesyl pyrophosphate
                     and geranyl pyrophosphate are the substrates for farnesyltransferase and geranylgeranyltransferase
                     I and II, respectively. These enzymes catalyze the prenylation of proteins (blue hexagons),
                     with farnesyltransferase catalyzing the addition of the 15-carbon farnesyl prenyl
                     lipids to the cysteine of the tetrapeptide CXXX (where X is one of a possible three
                     amino acids at the carboxyl terminus of the protein) and geranylgeranyltransferase
                     I and II catalyzing the addition of 20-carbon geranyl prenyl lipids to CXXX, CC or
                     CXC motifs. Farnesyltransferase inhibitors (FTI) block the farnesylation of proteins
                     such as Ras and also inhibit the replication of hepatitis delta virus (HDV) [18,19].
                     Similarly, geranylgeranyltransferase inhibitors (GGTI) block the geranylation of proteins
                     such as Rho and also inhibit the replication of HIV [17]. The prenylation of Ras and
                     Rho proteins promotes their association with membranes and is therefore necessary
                     for the targeting of these proteins to the plasma membrane, where they function.
                  </p>
               </caption>
               <graphic></graphic>
            </fig>
            <div id="T1">
               <label>Table 1</label>
               <caption>
                  <p>Host drug targets that have antiviral activity</p>
               </caption>
               <table>
                  <thead>
                     <tr>
                        <td>Virus family</td>
                        <td>Virus species</td>
                        <td>Host-cell target</td>
                        <td>Drug</td>
                        <td>Antiviral activity 
                           <i>in vitro</i>
                        </td>
                        <td>Antiviral activity 
                           <i>in vivo</i>
                        </td>
                        <td>References</td>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td>Poxviridae</td>
                        <td>Vaccinia virus</td>
                        <td>Abl tyrosine kinase</td>
                        <td>Gleevec</td>
                        <td>+</td>
                        <td>+</td>
                        <td>[13]</td>
                     </tr>
                     <tr>
                        <td>Herpesviridae</td>
                        <td>KSHV</td>
                        <td>c-Kit</td>
                        <td>Gleevec</td>
                        <td>+</td>
                        <td>+</td>
                        <td>[14,21]</td>
                     </tr>
                     <tr>
                        <td></td>
                        <td>KSHV</td>
                        <td>Vitamin D receptor</td>
                        <td>Vitamin D analog EB1089</td>
                        <td>+</td>
                        <td>-</td>
                        <td>[16]</td>
                     </tr>
                     <tr>
                        <td></td>
                        <td>HSV-1</td>
                        <td>EIF-2α</td>
                        <td>Salubrinal</td>
                        <td>+</td>
                        <td>-</td>
                        <td>[30]</td>
                     </tr>
                     <tr>
                        <td></td>
                        <td>HCMV</td>
                        <td>COX-2</td>
                        <td>BMS-279652</td>
                        <td>+</td>
                        <td>-</td>
                        <td>[15,23]</td>
                     </tr>
                     <tr>
                        <td></td>
                        <td></td>
                        <td></td>
                        <td>BMS-279654</td>
                        <td></td>
                        <td></td>
                        <td></td>
                     </tr>
                     <tr>
                        <td></td>
                        <td></td>
                        <td></td>
                        <td>BMS-279655</td>
                        <td></td>
                        <td></td>
                        <td></td>
                     </tr>
                     <tr>
                        <td></td>
                        <td></td>
                        <td></td>
                        <td>Indomethacin</td>
                        <td></td>
                        <td></td>
                        <td></td>
                     </tr>
                     <tr>
                        <td></td>
                        <td></td>
                        <td></td>
                        <td>Aspirin</td>
                        <td></td>
                        <td></td>
                        <td></td>
                     </tr>
                     <tr>
                        <td>Unclassified</td>
                        <td>Hepatitis D virus</td>
                        <td>Farnesyltransferase</td>
                        <td>FTI-277</td>
                        <td>+</td>
                        <td>+</td>
                        <td>[18,19]</td>
                     </tr>
                     <tr>
                        <td></td>
                        <td></td>
                        <td></td>
                        <td>FTI-2153</td>
                        <td></td>
                        <td></td>
                        <td></td>
                     </tr>
                     <tr>
                        <td>Hepadnaviridae</td>
                        <td>Hepatitis B virus</td>
                        <td>Heterogeneous nuclear ribonucleoprotein K (hnRNP K)</td>
                        <td>siRNA</td>
                        <td>+</td>
                        <td>-</td>
                        <td>[31]</td>
                     </tr>
                     <tr>
                        <td>Retroviridae</td>
                        <td>HIV</td>
                        <td>HMG-CoA reductase</td>
                        <td>Lovastatin</td>
                        <td>+</td>
                        <td>+</td>
                        <td>[17]</td>
                     </tr>
                     <tr>
                        <td></td>
                        <td>HIV</td>
                        <td>Geranylgeranyltransferase I</td>
                        <td>GGTI-286</td>
                        <td>+</td>
                        <td>-</td>
                        <td>[17]</td>
                     </tr>
                     <tr>
                        <td></td>
                        <td>HIV</td>
                        <td>ATM kinase</td>
                        <td>KU-55933</td>
                        <td>+</td>
                        <td>-</td>
                        <td>[28]</td>
                     </tr>
                     <tr>
                        <td></td>
                        <td>HIV</td>
                        <td>Deoxyhypusine synthase</td>
                        <td>CNI-1493</td>
                        <td>+</td>
                        <td>-</td>
                        <td>[29]</td>
                     </tr>
                     <tr>
                        <td></td>
                        <td>HIV</td>
                        <td>Histone deacetylase</td>
                        <td>Valporic acid</td>
                        <td>+</td>
                        <td>+</td>
                        <td>[32,33]</td>
                     </tr>
                     <tr>
                        <td>Flaviviridae</td>
                        <td>West Nile disease virus</td>
                        <td>c-Yes (Src family kinases)</td>
                        <td>PP2 SU6656</td>
                        <td>+</td>
                        <td>-</td>
                        <td>[20]</td>
                     </tr>
                  </tbody>
               </table>
            </div>
         </div>
      </back>
   </article>
</html>